PHARMA-THIM
0829.419.482 · rovalta.com · 08/11/2026
PHARMA-THIM
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMA-THIM is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Genappe. It employs on average 1,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0829.419.482
- Incorporation
- 21/09/2010
- Legal form
- Private limited company
- Registered office
- Grand route 89
1474 Genappe · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,3 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 249,1 k € | +3.1% | 241,7 k € | -8.1% | 262,9 k € | -2.7% | 270 k € | +37.3% | 196,7 k € |
| EBITDA | 190,3 k € | +7.8% | 176,5 k € | -11.4% | 199,2 k € | -4.3% | 208,1 k € | +42.4% | 146,1 k € |
| Operating result | 130,3 k € | +12.9% | 115,4 k € | -15.6% | 136,6 k € | +12.8% | 121,2 k € | +117% | 55,8 k € |
| Net result | 75,9 k € | +25.9% | 60,3 k € | -25.3% | 80,8 k € | +27.5% | 63,3 k € | +251% | 18 k € |
| Balance sheet | |||||||||
| Equity | 432,5 k € | +21.3% | 356,5 k € | +20.4% | 296,2 k € | +37.5% | 215,4 k € | +41.7% | 152,1 k € |
| Total assets | 883 k € | +13.2% | 779,9 k € | -4.4% | 816 k € | -0.2% | 817,6 k € | +4.0% | 786,4 k € |
| Cash | 27,6 k € | -68.8% | 88,3 k € | +14.5% | 77,1 k € | +30.1% | 59,3 k € | +3.4% | 57,3 k € |
| Debts | 450,5 k € | +6.4% | 423,3 k € | -18.3% | 517,9 k € | -13.8% | 601 k € | -5.0% | 632,7 k € |
| Other | |||||||||
| Workforce | 1,3 ETP | +8.3% | 1,2 ETP | 0.0% | 1,2 ETP | -40.0% | 2,0 ETP | 0.0% | 2,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
JEAN CHRISTOPHE BILLE | DirectorMandate2018 accountsended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2026 | 30/09/2025 | 27/09/2024 | 29/08/2023 | 30/09/2022 | 17/11/2021 |
| General meeting | 25/09/2026 | 29/09/2025 | 27/09/2024 | 20/07/2023 | 28/09/2022 | 21/10/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 25/09/2026 | 30/09/2026 | French | |
| Abridged model | 31/12/2024 | 29/09/2025 | 30/09/2025 | French | |
| Abridged model | 31/12/2023 | 27/09/2024 | 27/09/2024 | French | |
| Abridged model | 31/12/2022 | 20/07/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 28/09/2022 | 30/09/2022 | French | |
| Abridged model | 31/12/2020 | 21/10/2021 | 17/11/2021 | French | |
| Abridged model | 31/12/2019 | 26/10/2020 | 21/12/2020 | French | |
| Abridged model | 31/12/2018 | 16/09/2019 | 23/12/2019 | French | |
| Abridged model | 31/12/2017 | 17/09/2018 | 28/09/2018 | French | |
| Abridged model | 31/12/2016 | 21/09/2017 | 26/09/2017 | French | |
| Abridged model | 31/12/2015 | 19/09/2016 | 22/11/2016 | French | |
| Abridged model | 31/12/2014 | 28/10/2015 | 30/10/2015 | French | |
| Abridged model | 31/12/2013 | 31/05/2014 | 18/08/2014 | French | |
| Abridged model | 31/12/2012 | 08/10/2013 | 09/10/2013 | French | |
| Abridged model | 31/12/2011 | 10/10/2012 | 12/10/2012 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
JEAN CHRISTOPHE BILLE | DirectorMandate2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates05/01/2024MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Registered office30/11/2017SIEGE SOCIAL
- Restructuring07/01/2011RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring22/11/2010RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Other30/09/2010RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Grand route 89, 1474 WaysCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00548885 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMA-THIMCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00548885 |
Events
- 2025Annual accounts 202575,9 k €↑
- 2024Annual accounts 202460,3 k €↓
- 2023Annual accounts 202380,8 k €↑
- 2022Annual accounts 202263,3 k €↑
- 2021Annual accounts 202118 k €↓
- 2020Annual accounts 202053,9 k €↑
- 2019Annual accounts 20196,1 k €↑
- 2018Annual accounts 20184,2 k €↑
- 2017Annual accounts 2017-3,5 k €↓
- 2016Annual accounts 201614,7 k €↑
- 2015Annual accounts 20156,1 k €↓
- 2014Annual accounts 201433 k €↑
- 2013Annual accounts 2013-7,1 k €↓
- 2012Annual accounts 20129,7 k €↑
- 2011Annual accounts 20114,4 k €
- 21/09/2010IncorporationPrivate limited company